Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 39,861 | 26,058 | 27,617 | 32,440 | 26,496 |
| Cost of Goods | 14,542 | 10,720 | 11,165 | 14,552 | 12,458 |
| Gross Profit | 25,319 | 15,338 | 16,452 | 17,888 | 14,038 |
| Operating Expenses | 31,325 | 29,784 | 31,559 | 27,621 | 28,312 |
| Operating Income | -5,464 | -13,726 | -14,942 | -9,181 | -13,816 |
| Interest Expense | 885 | 897 | 900 | 643 | 444 |
| Other Income | 107 | 463 | -818 | -2,507 | 205 |
| Pre-tax Income | -6,242 | -14,160 | -16,660 | -12,331 | -14,055 |
| Income Tax | -243 | -1,145 | -680 | 354 | -1,168 |
| Net Income Continuous | -5,999 | -13,015 | -15,980 | -12,685 | -12,887 |
| Net Income | $-5,999 | $-13,015 | $-15,980 | $-12,685 | $-12,887 |
| EPS Basic Total Ops | -0.08 | -0.18 | -0.23 | -0.14 | -0.19 |
| EPS Basic Continuous Ops | -0.08 | -0.18 | -0.23 | -0.15 | -0.19 |
| EPS Diluted Total Ops | -0.08 | -0.18 | -0.23 | -0.14 | -0.19 |
| EPS Diluted Continuous Ops | -0.08 | -0.18 | -0.23 | -0.15 | -0.19 |
| EBITDA(a) | $-827 | $-8,748 | $-10,362 | $-5,156 | $-9,911 |